These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10206549)

  • 1. Synthesis and activity of gamma-(L-gamma-azaglutamyl)-S-(p-bromobenzyl)-L-cysteinylglycine: a metabolically stable inhibitor of glyoxalase I.
    Vince R; Brownell J; Akella LB
    Bioorg Med Chem Lett; 1999 Mar; 9(6):853-6. PubMed ID: 10206549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mammalian glyoxalase I (lactoylglutathione lyase) by N-acylated S-blocked glutathione derivatives as a probe for the role of the N-site of glutathione in glyoxalase I mechanism.
    Al-Timari A; Douglas KT
    Biochim Biophys Acta; 1986 Mar; 870(1):160-8. PubMed ID: 3947646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and activity of the glutathione analogue gamma-(L-gamma-azaglutamyl)-L-cysteinyl-glycine.
    Calcagni A; Dupré S; Lucente G; Luisi G; Pinnen F; Rossi D
    Int J Pept Protein Res; 1995 Nov; 46(5):434-9. PubMed ID: 8567188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence and nuclear relaxation enhancement studies of the binding of glutathione derivatives to manganese-reconstituted glyoxalase I from human erythrocytes. A model for the catalytic mechanism of the enzyme involving a hydrated metal ion.
    Sellin S; Eriksson LE; Mannervik B
    Biochemistry; 1982 Sep; 21(20):4850-7. PubMed ID: 7138835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of S-(p-bromobenzyl)glutathione diesters in vitro: a structure-activity study.
    Thornalley PJ; Ladan MJ; Ridgway SJ; Kang Y
    J Med Chem; 1996 Aug; 39(17):3409-11. PubMed ID: 8765525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the competitive inhibitor S-(p-bromobenzyl)-glutathione to glyoxalase I from yeast.
    Marmstal E; Mannervik B
    FEBS Lett; 1979 Jun; 102(1):162-4. PubMed ID: 378697
    [No Abstract]   [Full Text] [Related]  

  • 7. A metabolically stable tight-binding transition-state inhibitor of glyoxalase-I.
    More SS; Vince R
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6039-42. PubMed ID: 16997560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glyoxalase I by the enediol mimic S-(N-hydroxy-N-methylcarbamoyl)glutathione. The possible basis of a tumor-selective anticancer strategy.
    Hamilton DS; Creighton DJ
    J Biol Chem; 1992 Dec; 267(35):24933-6. PubMed ID: 1459997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and kinetic evaluation of S- and N-substituted cysteinylglycines as inhibitors of glyoxalase I.
    Lyon PA; Vince R
    J Med Chem; 1977 Jan; 20(1):77-88. PubMed ID: 833829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaryl-S-(p-bromobenzyl)-L-cysteinylglycine. A metabolically stable inhibitor of glyoxalase I.
    Vince R; Wolf M; Sanford C
    J Med Chem; 1973 Aug; 16(8):951-3. PubMed ID: 4147686
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and evaluation of N-alkanoyl-S-benzyl-L-cysteinylglutamic acid esters as glyoxalase I inhibitors and anticancer agents.
    Foye WO; Jan CM
    J Pharm Sci; 1984 Apr; 73(4):559-61. PubMed ID: 6726645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-fluorenylmethoxycarbonyl glutathione and diesters: inhibition of mammalian glyoxalase II.
    Chyan MK; Elia AC; Principato GB; Giovannini E; Rosi G; Norton SJ
    Enzyme Protein; 1994-1995; 48(3):164-73. PubMed ID: 8589803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR of the inhibition of glyoxalase by S-substituted glutathiones.
    Silipo C; Hansch C
    Farmaco Sci; 1979 Jan; 34(1):3-10. PubMed ID: 553818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II.
    Murthy NS; Bakeris T; Kavarana MJ; Hamilton DS; Lan Y; Creighton DJ
    J Med Chem; 1994 Jul; 37(14):2161-6. PubMed ID: 8035422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis and Biological Evaluation of Potent Human Glyoxalase I Inhibitors.
    Jin T; Zhai J; Liu X; Yue Y; Huang M; Li Z; Ni C; Deng Q; Sang Y; Yao Z; Zhang H; Hu X; Zheng ZB
    Chem Pharm Bull (Tokyo); 2017 May; 65(5):455-460. PubMed ID: 28320998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule probes of glyoxalase I and glyoxalase II.
    Barnard JF; Vander Jagt DL; Honek JF
    Biochim Biophys Acta; 1994 Sep; 1208(1):127-35. PubMed ID: 8086426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and study of glutaryl-S-(omega-aminoalkyl)-L-cysteinylglycines as inhibitors of glyoxalase I.
    Phillips GW; Norton SJ
    J Med Chem; 1975 May; 18(5):482-6. PubMed ID: 1171239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalent transition-state analogue inhibitors of human glyoxalase I.
    Zheng ZB; Creighton DJ
    Org Lett; 2003 Dec; 5(25):4855-8. PubMed ID: 14653691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified method for the purification of human red blood cell glyoxalase. I. Characteristics, immunoblotting, and inhibitor studies.
    Allen RE; Lo TW; Thornalley PJ
    J Protein Chem; 1993 Apr; 12(2):111-9. PubMed ID: 8489699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyoxalase 1 (GLO1) Inhibition or Genetic Overexpression Does Not Alter Ethanol's Locomotor Effects: Implications for GLO1 as a Therapeutic Target in Alcohol Use Disorders.
    Barkley-Levenson AM; Lagarda FA; Palmer AA
    Alcohol Clin Exp Res; 2018 May; 42(5):869-878. PubMed ID: 29532486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.